Shenyang Sunshine Pharmaceutical Co., Ltd.

This early-stage clinical trial is testing a new drug called SPGL008, both by itself and combined with an existing treatment (BCG), for people with high-risk non-muscle-invasive bladder cancer. The main goals are to find a safe dose and see if the treatment shows early signs of h…

This study is testing whether adding an experimental drug called SSGJ-706 to standard first-line chemotherapy can better control advanced cancers of the stomach, colon, pancreas, and esophagus. It will enroll about 300 adults with these cancers who have not yet received treatment…